SMTL ID : 8i2n.2 (1 other biounit)

The RIPK1 kinase domain in complex with QY7-2B compound

Coordinates

PDB Format Compare

Method

X-RAY DIFFRACTION 2.29 Å

Oligo State

monomer

Ligands

1 x O4U: ~{N}-methyl-1-[4-[[[1-methyl-5-(phenylmethyl)pyrazol-3-yl]carbonylamino]methyl]phenyl]benzimidazole-5-carboxamide(Non-covalent)

O4U.1: 19 residues within 4Å: Chain A: I.43, L.70, V.75, V.76, L.78, M.92, E.93, Y.94, M.95, G.98, L.129, H.136, L.145, I.154, A.155, D.156, L.157, S.161, F.162 13 PLIP interactions: 13 interactions with chain A Hydrophobic interactions: A:I.43, A:L.70, A:V.75, A:V.76, A:M.92, A:Y.94, A:L.129, A:L.145, A:D.156, A:L.157 Hydrogen bonds: A:M.95, A:D.156 pi-Stacking: A:F.162

Links

RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP

Citation

Qin, Y. et al., Structure-based development of potent and selective type-II kinase inhibitors of RIPK1. Acta Pharm Sin B (2024)

Release Date

2024-01-31

Peptides

Receptor-interacting serine/threonine-protein kinase 1: A

SMTL:PDB

SMTL Chain Id:
PDB Chain Id:

A
B

Receptor-interacting serine/threonine-protein kinase 1

Related Entries With Identical Sequence